INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Northrop Grumman Corporation - NOC — Neutral
NOC Accesswire — May 08, 2025NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Northrop Grumman Corporation ("Northrop Grumman" or the "Company") (NYSE:NOC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI — Neutral
ICUI Accesswire — May 08, 2025NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc.("ICU" or the "Company") (NASDAQ:ICUI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Backblaze, Inc. - BLZE — Neutral
BLZE Accesswire — May 08, 2025NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Backblaze, Inc.("Backblaze" or the "Company") (NASDAQ:BLZE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CarMax, Inc. - KMX — Neutral
KMX Accesswire — May 08, 2025NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of CarMax, Inc.("CarMax" or the "Company") (NYSE:KMX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Movado Group, Inc. - MOV — Neutral
MOV Accesswire — May 08, 2025NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Movado Group, Inc.("Movado" or the "Company") (NYSE:MOV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DuPont de Nemours, Inc. - DD — Neutral
DD Accesswire — May 08, 2025NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. ("DuPont" or the "Company") (NYSE:DD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TechTarget, Inc. - TTGT — Neutral
TTGT Accesswire — May 08, 2025NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of TechTarget, Inc. ("TechTarget" or the "Company") (NASDAQ:TTGT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kyndryl Holdings, Inc. - KD — Neutral
KMX Accesswire — May 08, 2025NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE:KMX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Senti Biosciences, Inc. - SNTI — Neutral
SNTI Accesswire — May 08, 2025NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Senti Biosciences, Inc.("Senti" or the "Company") (NASDAQ:SNTI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

United States Antimony Corporation Reports Record First Quarter 2025 Financial and Operating Results — Neutral
UAMY Accesswire — May 08, 2025Revenues Up 128% YOY Gross Profit Up 302% YOY Net Income Up 269% YOY "The Critical Minerals and ZEO Company" DALLAS, TX / ACCESS Newswire / May 8, 2025 / United States Antimony Corporation ("USAC" or the "Company" or "U.S. Antimony Corporation"), (NYSE:UAMY) reported today its first quarter 2025 financial and operational results. Revenues for the first three months of 2025 increased 128% or $3.9 million, to $7 million.

The Houston oil producer posted first-quarter earnings of $2.8 billion, or $2.23 a share, up from $2.6 billion, or $2.15 a share, a year earlier.

QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock Up — Positive
QGEN Zacks Investment Research — May 08, 2025QGEN's quarterly performance benefits from a resilient portfolio in the first quarter of 2025.

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance — Neutral
VCEL GlobeNewsWire — May 08, 2025Record First Quarter MACI Revenue of $46.3 Million and First Quarter Total Revenue of $52.6 Million Approximately 400 MACI Arthro Surgeons Trained to Date, with Year-to-Date Biopsy Growth Over 30% for Trained Surgeons Second Quarter Total Revenue and MACI Revenue Growth Expected to be in the Low- to Mid-20% Range Full-Year 2025 Revenue Guidance Reaffirmed and Profitability Guidance Raised Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the …

Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY — Neutral
SYRA PRNewsWire — May 08, 2025Revenue increase led by Population Health's 261% YoY Expansion Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY Continued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024 A conference call will be held today, Thursday, May 8, at 9:00 am ET CARMEL, Ind. , May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the first quarter ended March 31, 2025.

SAN DIEGO , May 8, 2025 /PRNewswire/ -- Sempra (NYSE: SRE) today reported first-quarter 2025 earnings, prepared in accordance with Generally Accepted Accounting Principles (GAAP), of $906 million or $1.39 per diluted share, compared to first-quarter 2024 GAAP earnings of $801 million or $1.26 per diluted share. On an adjusted basis, first-quarter 2025 earnings were $942 million or $1.44 per diluted share, compared to $854 million or $1.34 per diluted share in 2024.

Brixmor Property Group: A Safe Bet In An Uncertain Economy — Positive
BRX Seeking Alpha — May 08, 2025Brixmor Property Group (BRX) focuses on resilient, grocery-anchored retail centers, showing strong leasing spreads and capital-efficient strategies, despite economic uncertainties. BRX's Q1 performance highlights a 5.4% revenue increase, strong tenant demand, and a stable liquidity position, despite rising operating and interest expenses. Key risks include tenant bankruptcies, interest rate sensitivity, and redevelopment execution risks, potentially impacting occupancy and financial performance.

CRMT and BSAC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 8, 2025.

Bain Capital Specialty Finance: Lower Earnings But Fundamentals & Dividend Coverage Are Strong — Positive
BCSF Seeking Alpha — May 08, 2025BCSF remains a buy due to strong fundamentals, resilient earnings, low non-accruals, and a generous 11.4% dividend yield, despite recent price declines. BCSF's diverse portfolio, with 93.2% in floating rate debt, positions it well to benefit from the current high interest rate environment. Q1 earnings were solid, with net investment income of $0.50 per share, and the portfolio's NAV has remained stable, indicating effective strategy execution.

Tesla (NASDAQ: TSLA) Stock Price Prediction and Forecast 2025-2030 (May 8) — Neutral
TSLA 24/7 Wall Street — May 08, 2025Shares of Tesla Inc. (NASDAQ: TSLA) rose fractionally on Wednesday, after retreating in the past few days on news of declining sales in China.

Interactive Strength Inc. (Nasdaq:TRNR) Responds to FAQ's About Sportstech's LTM Revenue of $54M and EBITDA of $5M through April 2025 — Neutral
TRNR Accesswire — May 08, 2025AUSTIN, TX / ACCESS Newswire / May 8, 2025 / Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Sportstech and Wattbike, today announced that it has updated its investor FAQ's on its investor website in response to shareholder questions on yesterday's updates about Sportstech's LTM financial performance. For more commentary, information and details on the rationale for and structure of the expected acquisition, please see TRNR's investor presentation on the Company's investor website as well as its required filings with the US Securities & …
